SSG
BLFS icon

Summit Securities Group’s BioLife Solutions BLFS Stock Holding History

Summit Securities Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,978
Closed -$107K – 1045
2025
Q2 		$107K Buy
+4,978
New +$112K 0.02% 351

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Summit Securities Group's BLFS Position: Q3 2025 in Review

Summit Securities Group sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 4,978 shares — an estimated $107K sold.

Summit Securities Group first reported a position in BLFS in Q2 2025 and held it in 1 quarter. The position peaked at $107K in Q2 2025. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Summit Securities Group reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Summit Securities Group sold 4,978 BioLife Solutions shares in Q3 2025, an estimated $107K.
  • Summit Securities Group first reported a position in BioLife Solutions in Q2 2025 and held it in 1 quarter.
  • Summit Securities Group's BioLife Solutions position peaked at $107K in Q2 2025.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.